MAPT and Alzheimer disease: AD is pathologically characterized by two prominent lesions: the excessive accumulation of amyloid-β (Aβ) and the hyperphosphorylation of microtubule-associated protein Tau hyperphosphorylated microtubule-associated proteins (Tau), both of which contribute to neuronal dysfunction and loss (Wang et al., 2020).